Impaired circulating myeloid DCs from myeloma patients

References

• Banchereau J, Briere F', Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767— 811.
   PubMed Web of Science ®Google Scholar
• Reid SD, Penna G, Adorini L. The control of T cell responses bydendritic cell subsets. Curr Opin Immunol 2000;12:114–21.
   Google Scholar
• Fearnley DB, Whyte LF, Carnoutsos SA et al. Monitoring humanblood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 1999;93:728— 36.
   PubMed Web of Science ®Google Scholar
• Upham JW, Lundahl J, Liang H et al. Simplified quantitation ofmyeloid dendritic cells in peripheral blood using flow cytometry. Cytometry 2000;40:50— 9.
   Google Scholar
• Willmann K, Dunne JF. A flow cytometric immune function assay for human peripheral blood dendritic cells. 7 Leukoc Biol 2000;67:536–44.
   Google Scholar
• Grabbe S, Kampgen E, Schuler G. Dendritic cells: multi-lineal and multi-functional. Immunol Today 2000;21:431— 3.
   Google Scholar
• Woodhead VE, Binks MH, Chain BM, Katz DR. From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition. Immunology 1998;94:552–9.
   PubMed Web of Science ®Google Scholar
• de St Groth BE DCs and peripheral T cell tolerance. Semin Immunol 2001;13:311–22.
   Google Scholar
• Lanzavecchia A, Sallusto E The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2001;13:291–8.
   PubMed Web of Science ®Google Scholar
• Morse MA, Lyerly HK. Dendritic cell-based immunization for cancer therapy. Adv Exp Med Biol 2000;465:335–46.
   PubMed Web of Science ®Google Scholar
• Reid DC. Dendritic cells and immunotherapy for malignant disease. Br 7 Haematol 2001;112:874— 87.
   Google Scholar
• Schreurs MW, Eggert AA, Punt CJ et al. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy. Grit Rev Oncog 2000;11:1–17.
   PubMed Web of Science ®Google Scholar
• Geiger JD, Hutchinson RJ, Hohenkirk LF et al. Vaccination ofpediatric solid tumor patients with rumor lysate-pulsed den-dritic cells can expand specific T cells and mediate rumor regression. Cancer Res 2001;61:8513–9.
   PubMed Web of Science ®Google Scholar
• Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanomapatients with peptide or rumor-lysate-pulsed dendritic cells. Nat Med 1998;4:328–32.
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Tachibana M, Horiguchi Y et al. Immunotherapyof bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide. Clin Cancer Res 2001;7:23 — 31.
   Google Scholar
• Brown RD, Pope B, Murray A et al. Dendritic cells from patientswith myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD4OLT stimulation because of inhibition by transforming growth factor-betal and interleukin-10. Blood 2001;98:2992— 8.
   PubMed Web of Science ®Google Scholar
• Mohty M, Jarrossay D, Lafage-Pochitaloff M et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001;98:3750— 6.
   Google Scholar
• Ninomiya T, Akbar SM, Masumoto T et al. Dendritic cells withimmature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. 7 Hepatol 1999;31:323— 31.
   Google Scholar
• Savary CA, Grazziutti ML, Melichar B et al. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients. Cancer Immunol Immunother 1998;45:234 — 40.
   Google Scholar
• Robinson SP, Patterson S, English N et al. Human peripheral blood contains two distinct lineages of dendritic cells. Eur Immunol 1999;29:2769— 78.
   Google Scholar
• Ho CS, Munster D, Pyke CM et al. Spontaneous generation andsurvival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 2002;99:2897— 904.
   Google Scholar
• Kohrgruber N, Halanek N, Groger M et al. Survival, maturation,and function of CD11c — and CD11c± peripheral blooddendritic cells are differentially regulated by cytokines. Immunol 1999;163:3250— 9.
   Google Scholar
• Almand B, Resser JR, Lindman B et al. Clinical significance ofdefective dendritic cell differentiation in cancer. Clin Cancer Res 2000;6:1755–66.
   PubMed Web of Science ®Google Scholar
• Hasebe H, Nagayama H, Sato K et al. Dysfunctional regulationof the development of monocyte-derived dendritic cells in cancer patients. Biomed Pharmacother 2000;54:291–8.
   Google Scholar
• Ratta M, Fagnoni F, Curti A et al. Dendritic cells are functionallydefective in multiple myeloma: the role of interleukin-6. Blood 2002;100:230— 7.
   PubMed Web of Science ®Google Scholar
• Vanderheyde N, Verhasselt V, Goldman M, Willems E Inhibi-tion of human dendritic cell functions by methylprednisolone. Transplantation 1999;67:1342— 7.
   Google Scholar
• Pfeiffer S, Gooding RP, Apperley JF et al. Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors. Br 7 Haematol 1997;98:973–82.
   PubMed Web of Science ®Google Scholar
• Almand B, Clark JI, Nikitina E et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. 7 Immunol 2001;166:678— 89.
   Google Scholar
• Labeur MS, Roters B, Pers B et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. 7 Immunol 1999;162:168–75.
   PubMed Web of Science ®Google Scholar